Skip to main content
SpringerLink
Log in

A 40-Year-Old Woman with Chronic Recurrent Headache (Migraine)

  • Chapter
  • First Online:
Practical Chronic Pain Management

  • 1012 Accesses

Abstract

Migraine is a common heritable disease, affecting 1 in 10 people worldwide. Migraine can present in a variety of ways and frequently goes undiagnosed and untreated for years. For some, migraine is an occasional nuisance, but for many more it is a life-long condition marked by exacerbations and remissions. Migraine is three times more common in women and tends to emerge or shift around hormonal milestones such as menarche, the birth of a child, or menopause. The pharmacologic management of migraine can be broken down into acute treatment and preventive therapy. A variety of FDA-approved and off-label pharmacologic treatments are available. With treatment, most patients do well.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9.

    CAS  PubMed  Google Scholar 

  2. Bigal ME, Lipton RB. The epidemiology, burden, and comorbidities of migraine. Neurol Clin. 2009;27(2):321–34.

    PubMed  Google Scholar 

  3. Chang FY, Lu CL. Irritable bowel syndrome and migraine: bystanders or partners? J neurogastroenterol mot. 2013;19(3):301–11.

    Google Scholar 

  4. Parkman HP, Yates K, Hasler WL, Nguyen L, Pasricha PJ, Snape WJ, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Gastroenterology. 2011;140(1):101–15.

    PubMed  Google Scholar 

  5. Warren JW, Howard FM, Cross RK, Good JL, Weissman MM, Wesselmann U, et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology. 2009;73(1):52–7.

    PubMed  Google Scholar 

  6. Pavlovic JM, Buse DC, Sollars CM, Haut S, Lipton RB. Trigger factors and premonitory features of migraine attacks: summary of studies. Headache: The Journal of Head and Face Pain. 2014;54(10):1670–9.

    Google Scholar 

  7. Sances G, Granella F, Nappi R, Fignon A, Ghiotto N, Polatti F, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia : an international journal of headache. 2003;23(3):197–205.

    CAS  PubMed  Google Scholar 

  8. Adeney KL, Williams MA. Migraine headaches and preeclampsia: an epidemiologic review. Headache: The Journal of Head and Face Pain. 2006;46(5):794–803.

    Google Scholar 

  9. Stein GS. Headaches in the first post partum week and their relationship to migraine. J Head Face Pain. 1981;21(5):201–5.

    CAS  Google Scholar 

  10. Arnold M. Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia : an international journal of headache. 2018;38(1):1–211.

    Google Scholar 

  11. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort the GEM study. Neurology. 1999;53(3):537.

    CAS  PubMed  Google Scholar 

  12. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American migraine study II. Headache. 2001;41(7):646–57.

    CAS  PubMed  Google Scholar 

  13. Schreiber CP, Hutchinson S, Webster CJ, Ames M, Richardson MS, Powers C. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed sinus headache. Arch Intern Med. 2004;164(16):1769–72.

    PubMed  Google Scholar 

  14. Johnston MM, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: implications for headache disorders. Ann Neurol. 2013;74(1):145–8.

    PubMed  Google Scholar 

  15. Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain. 2013;154:S44–53.

    CAS  PubMed  Google Scholar 

  16. Giffin NJ, Lipton RB, Silberstein SD, Olesen J, Goadsby PJ. The migraine postdrome an electronic diary study. Neurology. 2016;87(3):309–13.

    PubMed  PubMed Central  Google Scholar 

  17. Gv S, Van der Grond J, Cv K, Van der Geest R, Terwindt G, Ferrari M. Migraine headache is not associated with cerebral or meningeal vasodilatation—a 3T magnetic resonance angiography study. J neurol. 2008;131(8):2192–200.

    Google Scholar 

  18. Asghar MS, Hansen AE, Amin FM, Van Der Geest R, Koning P, Larsson HB, et al. Evidence for a vascular factor in migraine. Ann Neurol. 2011;69(4):635–45.

    PubMed  Google Scholar 

  19. Amin FM, Asghar MS, Hougaard A, Hansen AE, Larsen VA, de Koning PJ, et al. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol. 2013;12(5):454–61.

    PubMed  Google Scholar 

  20. Schwedt TJ, Chong CD, Wu T, Gaw N, Fu Y, Li J. Accurate classification of chronic migraine via brain magnetic resonance imaging. J Head Face Pain. 2015;55(6):762–77.

    Google Scholar 

  21. Schwedt TJ, Chiang C-C, Chong CD, Dodick DW. Functional MRI of migraine. The Lancet Neurology. 2015;14(1):81–91.

    PubMed  Google Scholar 

  22. Close LN, Eftekhari S, Wang M, Charles AC, Russo AF. Cortical spreading depression as a site of origin for migraine: role of CGRP. Cephalalgia : An inter J headache. 2019;39(3):428–34.

    Google Scholar 

  23. Hadjikhani N, Del Rio MS, Wu O, Schwartz D, Bakker D, Fischl B, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci. 2001;98(8):4687–92.

    CAS  PubMed  Google Scholar 

  24. Karatas H, Erdener SE, Gursoy-Ozdemir Y, Lule S, Eren-Koçak E, Sen ZD, et al. Spreading depression triggers headache by activating neuronal Panx1 channels. Science. 2013;339(6123):1092–5.

    CAS  PubMed  Google Scholar 

  25. Dodick DW. A phase‐by‐phase review of migraine pathophysiology. Headache: The Journal of Head and Face Pain. 2018;58:4–16.

    Google Scholar 

  26. Lipton RB, Stewart WF, Stone AM, Láinez MJ, Sawyer JP. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: a randomized trial. Jama. 2000;284(20):2599–605.

    Google Scholar 

  27. Charles A, Hansen JM. Migraine aura: new ideas about cause, classification, and clinical significance. Curr Opin Neurol. 2015;28(3):255–60.

    PubMed  Google Scholar 

  28. Becker WJ. Acute migraine treatment. Cont Lifelong Learning Neurol. 2015;21(4, Headache):953–72.

    Google Scholar 

  29. Becker WJ. Acute migraine treatment in adults. Headache. 2015;55(6):778–93.

    PubMed  Google Scholar 

  30. Wijemanne S, Jankovic J, Evans RW. Movement disorders from the use of metoclopramide and other antiemetics in the treatment of migraine. Headache. 2016;56(1):153–61.

    PubMed  Google Scholar 

  31. Schwedt TJ. Preventive therapy of migraine. Continuum. 2018;24(4):1052–65.

    PubMed  Google Scholar 

  32. Topiramate prescribing information.

    Google Scholar 

  33. Divalproex sodium FDA Prescribing Information.

    Google Scholar 

  34. Propranolol FDA Prescribing Information.

    Google Scholar 

  35. Timolol maleate – Link to FDA Prescribing Information.

    Google Scholar 

  36. OnabotulinumtoxinA – FDA Prescribing Information.

    Google Scholar 

  37. Erenumab - FDA Prescribing Information.

    Google Scholar 

  38. Fremanezumab - FDA Prescribing Information.

    Google Scholar 

  39. Galcanezumab - FDA Prescribing Information.

    Google Scholar 

  40. Eptinezumab - FDA Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761119s000lbl.pdf.

  41. Silberstein S, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults report of the quality standards Subcommittee of the American Academy of neurology and the American headache society. Neurology. 2012;78(17):1337–45.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 2013;(6). https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010608/epdf/full.

  43. Burch R. Antidepressants for preventive treatment of migraine. Curr Treat Options Neurol. 2019;21(4):18.

    PubMed  Google Scholar 

  44. Shamliyan TA, Kane RL, Taylor FR. Migraine in adults: Preventive pharmacologic treatments. 2013.

    Google Scholar 

  45. Neri I, Granella F, Nappi R, Manzoni G, Facchinetti F, Genazzani A. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas. 1993;17(1):31–7.

    CAS  PubMed  Google Scholar 

  46. members: IHSCTS, Tfelt-Hansen P, Pascual J, Ramadan N, Dahlöf C, D’Amico D, et al. Guidelines for controlled trials of drugs in migraine: a guide for investigators. Cephalalgia. 2012;32(1):6–38.

    Google Scholar 

  47. Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, et al. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2017;16(11):877–97.

    Google Scholar 

  48. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390(10100):1211–1259.

    Google Scholar 

  49. Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307–15.

    PubMed  Google Scholar 

  50. Martin VT. The diagnostic evaluation of secondary headache disorders. Headache: The Journal of Head and Face Pain. 2011;51(2):346–52.

    Google Scholar 

  51. Loder E, Weizenbaum E, Frishberg B, Silberstein S, Force AHSCWT. Choosing wisely in headache medicine: the a merican headache Society's list of five things physicians and patients should question. Headache: The Journal of Head and Face Pain. 2013;53(10):1651–9.

    Google Scholar 

  52. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol. 2004;61(9):1366–8.

    PubMed  Google Scholar 

  53. Bashir A, Lipton RB, Ashina S, Ashina M. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology. 2013;81(14):1260–8.

    PubMed  PubMed Central  Google Scholar 

  54. Ong JJY, Wei DY, Goadsby PJ. Recent advances in pharmacotherapy for migraine prevention: from pathophysiology to new drugs. Drugs. 2018;78(4):411–37.

    CAS  PubMed  Google Scholar 

  55. Lasmiditan - FDA Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211280s000lbl.pdf.

  56. Dodick DW. Pearls: headache. Semin Neurol. 2010;30(1):74–81.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Sciences, University of Vermont, Burlington, VT, USA

    Adam S. Sprouse Blum

Authors
  1. Adam S. Sprouse Blum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam S. Sprouse Blum .

Editor information

Editors and Affiliations

  1. Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL, USA

    Tariq Malik

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sprouse Blum, A.S. (2020). A 40-Year-Old Woman with Chronic Recurrent Headache (Migraine). In: Malik, T. (eds) Practical Chronic Pain Management. Springer, Cham. https://doi.org/10.1007/978-3-030-46675-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-46675-6_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-46674-9

  • Online ISBN: 978-3-030-46675-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation